150 related articles for article (PubMed ID: 25082313)
21. Prognostic value of immunohistochemical profile and response to high-dose methotrexate therapy in primary CNS lymphoma.
Momota H; Narita Y; Maeshima AM; Miyakita Y; Shinomiya A; Maruyama T; Muragaki Y; Shibui S
J Neurooncol; 2010 Jul; 98(3):341-8. PubMed ID: 20012911
[TBL] [Abstract][Full Text] [Related]
22. Primary central nervous system lymphoma: a profile of 26 cases from Western India.
Agarwal PA; Menon S; Smruti BK; Singhal BS
Neurol India; 2009; 57(6):756-63. PubMed ID: 20139505
[TBL] [Abstract][Full Text] [Related]
23. [Adult acute lymphoblastic leukemia with central nervous system involvement: an overview].
Thomas X; Pavan L; Le QH
Bull Cancer; 2008; 95(7):707-15. PubMed ID: 18755650
[TBL] [Abstract][Full Text] [Related]
24. Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis.
Abrey LE; Moskowitz CH; Mason WP; Crump M; Stewart D; Forsyth P; Paleologos N; Correa DD; Anderson ND; Caron D; Zelenetz A; Nimer SD; DeAngelis LM
J Clin Oncol; 2003 Nov; 21(22):4151-6. PubMed ID: 14615443
[TBL] [Abstract][Full Text] [Related]
25. Outcome of elderly patients with primary CNS lymphoma in the G-PCNSL-SG-1 trial.
Roth P; Martus P; Kiewe P; Möhle R; Klasen H; Rauch M; Röth A; Kaun S; Thiel E; Korfel A; Weller M
Neurology; 2012 Aug; 79(9):890-6. PubMed ID: 22895585
[TBL] [Abstract][Full Text] [Related]
26. Systemic relapses of primary CNS lymphomas (PCNSL): a LOC network study.
Dufour J; Choquet S; Hoang-Xuan K; Schmitt A; Ahle G; Houot R; Taillandier L; Gressin R; Casasnovas O; Marolleau JP; Tamburini J; Serrier C; Perez E; Paillassa J; Gyan E; Chauchet A; Ursu R; Kas A; Soussain C; Houillier C
Ann Hematol; 2023 May; 102(5):1159-1169. PubMed ID: 36991231
[TBL] [Abstract][Full Text] [Related]
27. Primary CNS lymphoma: a clinician's guide.
Schäfer N; Glas M; Herrlinger U
Expert Rev Neurother; 2012 Oct; 12(10):1197-206. PubMed ID: 23082736
[TBL] [Abstract][Full Text] [Related]
28. Results of combined-modality therapy for primary and secondary malignant lymphoma of the central nervous system (CNS).
Kawamura T; Koga S; Okamoto M; Kanno T; Iwamura H
Radiat Med; 2001; 19(3):145-9. PubMed ID: 11467381
[TBL] [Abstract][Full Text] [Related]
29. [Primary central nervous system lymphoma].
Royer-Perron L; Hoang-Xuan K; Houillier C
Rev Prat; 2016 Apr; 66(4):419-422. PubMed ID: 30512707
[TBL] [Abstract][Full Text] [Related]
30. Central nervous system involvement in intravascular large B-cell lymphoma: a retrospective analysis of 109 patients.
Shimada K; Murase T; Matsue K; Okamoto M; Ichikawa N; Tsukamoto N; Niitsu N; Miwa H; Asaoku H; Kosugi H; Kikuchi A; Matsumoto M; Saburi Y; Masaki Y; Yamamoto K; Yamaguchi M; Nakamura S; Naoe T; Kinoshita T;
Cancer Sci; 2010 Jun; 101(6):1480-6. PubMed ID: 20412122
[TBL] [Abstract][Full Text] [Related]
31. High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma.
Cheng T; Forsyth P; Chaudhry A; Morris D; Glück S; Russell JA; Stewart DA
Bone Marrow Transplant; 2003 Apr; 31(8):679-85. PubMed ID: 12692608
[TBL] [Abstract][Full Text] [Related]
32. [Chemotherapy in conjunction with blood brain barrier disruption in the treatment of primary central nervous system lymphoma].
Kuittinen O; Siniluoto T; Isokangas M; Turpeenniemi-Hujanen T; Peltonen J; Alahuhta S; Sonkajärvi E
Duodecim; 2013; 129(15):1563-70. PubMed ID: 24163974
[TBL] [Abstract][Full Text] [Related]
33. Treatment of relapsed central nervous system lymphoma with high-dose methotrexate.
Plotkin SR; Betensky RA; Hochberg FH; Grossman SA; Lesser GJ; Nabors LB; Chon B; Batchelor TT
Clin Cancer Res; 2004 Sep; 10(17):5643-6. PubMed ID: 15355887
[TBL] [Abstract][Full Text] [Related]
34. High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma.
Illerhaus G; Marks R; Ihorst G; Guttenberger R; Ostertag C; Derigs G; Frickhofen N; Feuerhake F; Volk B; Finke J
J Clin Oncol; 2006 Aug; 24(24):3865-70. PubMed ID: 16864853
[TBL] [Abstract][Full Text] [Related]
35. Patterns of relapse in primary central nervous system lymphoma: inferences regarding the role of the neuro-vascular unit and monoclonal antibodies in treating occult CNS disease.
Ambady P; Fu R; Netto JP; Kersch C; Firkins J; Doolittle ND; Neuwelt EA
Fluids Barriers CNS; 2017 Jun; 14(1):16. PubMed ID: 28577579
[TBL] [Abstract][Full Text] [Related]
36. Pemetrexed in the treatment of relapsed/refractory primary central nervous system lymphoma.
Raizer JJ; Rademaker A; Evens AM; Rice L; Schwartz M; Chandler JP; Getch CC; Tellez C; Grimm SA
Cancer; 2012 Aug; 118(15):3743-8. PubMed ID: 22179954
[TBL] [Abstract][Full Text] [Related]
37. Primary central nervous system lymphoma with lymphomatosis cerebri in an immunocompetent child: MRI and 18F-FDG PET-CT findings.
Jain TK; Sharma P; Suman SK; Faizi NA; Bal C; Kumar R
Rev Esp Med Nucl Imagen Mol; 2013; 32(6):394-6. PubMed ID: 23743243
[TBL] [Abstract][Full Text] [Related]
38. Treatment of primary CNS lymphoma with high-dose methotrexate in immunocompetent pediatric patients.
Shah AC; Kelly DR; Nabors LB; Oakes WJ; Hilliard LM; Reddy AT
Pediatr Blood Cancer; 2010 Dec; 55(6):1227-30. PubMed ID: 20882580
[TBL] [Abstract][Full Text] [Related]
39. Relapse of primary central nervous system lymphoma 13 years after high-dose methotrexate-based polychemotherapy.
Steinbeck JA; Stuplich M; Blasius E; Pels H; Glas M; Schlegel U; Herrlinger U
J Clin Neurosci; 2011 Nov; 18(11):1554-5. PubMed ID: 21868233
[TBL] [Abstract][Full Text] [Related]
40. [Recent advances in the treatment of primary central nervous system lymphoma].
Nakamaki T
Brain Nerve; 2014 Aug; 66(8):969-79. PubMed ID: 25082318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
